Silica nanoparticles have entered clinical trials for a variety of biomedical applications, including oral drug delivery, diagnostics, plasmonic resonance and photothermal ablation therapy. Preliminary results indicate the safety, efficacy and viability of silica nanoparticles under these clinical scenarios.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496429 | PMC |
http://dx.doi.org/10.1038/s41578-021-00385-x | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!